Sunshine Biopharma signs licence deal for Covid-19 treatment
Pharmaceutical Technology
MARCH 1, 2023
Sunshine Biopharma has signed an exclusive global licence deal with the University of Arizona for PLpro-based Covid-19 treatment. Since February last year, Sunshine Biopharma has been working along with the University of Arizona on this project. Early R&D projects coverage on Pharmaceutical Technology is supported by Mimotopes.
Let's personalize your content